The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of Gynecologic Cancer Intergroup (GCIG) CA125 criteria to evaluate cell cycle checkpoint kinase 1 inhibitor (CHK1i) prexasertib response and disease progression (PD) in recurrent high-grade serous ovarian cancer (HGSOC).
 
Kristen Ibanez
No Relationships to Disclose
 
Duncan Donohue
No Relationships to Disclose
 
Tyler Malys
No Relationships to Disclose
 
Jung-Min Lee
Consulting or Advisory Role - Acrivon Therapeutics
Research Funding - Acrivon Therapeutics (Inst); AstraZeneca (Inst)